-
Bradford Protein Assay Kit: Practical Protocol
2026-08-24
The Bradford Protein Assay Kit (SKU K4103) provides a rapid colorimetric approach for measuring protein concentration in solution using Coomassie Brilliant Blue G-250 and a BSA standard curve. It is appropriate for routine biochemical and molecular biology workflows, but samples containing detergents, strongly alkaline reagents, or concentrations outside the stated range require matrix assessment or dilution.
-
BFH772 (VEGFR2 inhibitor): Workflow Guide
2026-08-23
BFH772 is a selective VEGFR2 kinase inhibitor for controlled angiogenesis and tumor-model research, with reported biochemical potency and organic-solvent solubility. It is suitable for VEGFR2-focused assays but should not be used without additional validation in water-based formulations, broad-spectrum kinase studies, or protocols requiring literature-derived dosing that is not provided in the product dossier.
-
Capecitabine in Patient-Matched Tumor Assays
2026-08-22
Capecitabine is examined here as an activation-dependent probe for patient-matched tumor organoid and stromal assays. Learn how tumor microenvironment, thymidine phosphorylase biology, and compartment-specific responses can improve preclinical oncology research.
-
SU6656 Src Tyrosine Kinases Inhibitor Guide
2026-08-22
SU6656 is a Src tyrosine kinases inhibitor used in cancer research, platelet biology, and preclinical radiotherapy studies. Available evidence links it to inhibition of PDGF-/Src-driven mitogenesis, megakaryocyte polyploidization, and enhancement of radiation-induced antiangiogenic effects, but the 2026 hiPSC platelet study did not directly validate SU6656 in its optimized protocol.
-
CTOP for μ-Opioid Receptor Signaling Studies
2026-08-21
CTOP enables selective μ-opioid receptor blockade across binding, signaling, tissue, and behavioral assays. This guide translates a 2024 brain-to-spinal circuit study into practical workflows for separating receptor-dependent analgesia, mechanical hypersensitivity, and tolerance.
-
Honokiol for NF-κB and T-Cell Metabolism
2026-08-20
Learn how Honokiol can be integrated into inflammation, oxidative-stress, and CD8+ T-cell immunometabolism workflows without confusing pathway modulation with direct metabolic reprogramming. This practical guide covers compound preparation, assay design, controls, troubleshooting, and hypothesis-driven extensions of a 2024 PKM alternative-splicing study.
-
IAM LC vs LEKC for Pulmonary Permeability
2026-08-20
This 2024 Journal of Chromatography A study provides a direct comparison of immobilised artificial membrane liquid chromatography and liposome electrokinetic capillary chromatography using 26 drug-like molecules. LEKC better reflected apparent pulmonary permeability, whereas IAM LC offered broader compound coverage and simpler high-throughput implementation, defining complementary roles for biomimetic screening.
-
Angiotensin 1/2 (1-6): A Translational RAS Probe
2026-08-19
A mechanistic and strategic guide to using Angiotensin 1/2 (1-6), the Asp-Arg-Val-Tyr-Ile-His hexapeptide, in renin-angiotensin system research, cardiovascular regulation studies, renal function research, and carefully bounded viral-receptor investigations.
-
Fosinopril Sodium Research Workflows
2026-08-19
Build more reproducible hypertension research and cardiovascular disease model workflows with Fosinopril sodium, an ACE inhibitor distinguished by phosphinic acid zinc-ion binding and prodrug activation. Practical guidance covers solution preparation, exposure design, renal hemodynamics modulation, blood pressure reduction, and troubleshooting across in vitro and in vivo studies.
-
Metoprolol Tartrate: Selectivity in Assay Design
2026-08-18
Metoprolol Tartrate is a β1-adrenergic blocking agent for dissecting cardiac signaling while limiting confounding nonselective β-receptor effects. This guide translates transplant-regeneration evidence into practical assay design, formulation, and interpretation decisions.
-
Honokiol at the Immunometabolism–Cancer Interface
2026-08-18
A translational framework for using Honokiol to investigate the intersection of NF-κB signaling, oxidative stress, angiogenesis, and CD8+ T-cell metabolic flexibility without overstating mechanistic evidence.
-
AG-120 (Ivosidenib): Translating IDH1 Biology
2026-08-17
AG-120 (Ivosidenib) offers translational researchers a direct way to interrogate mutant IDH1 biology, from 2-hydroxyglutarate reduction to differentiation. This perspective connects product-level assay design with emerging evidence that CD44-driven metabolic rewiring sustains oncometabolite production in IDH-mutant leukemia, helping researchers design more informative AML studies and resistance experiments.
-
H 89 2HCl in cAMP/PKA Assays
2026-08-17
H 89 2HCl provides a practical way to separate PKA-dependent phosphorylation from upstream cAMP production in neuronal and cell-signaling experiments. This guide translates its biochemical profile into assay workflows for neurite outgrowth, striatal neuron studies, and mechanistic follow-up of the Neuroligin 1–D2-MSN findings.
-
BAY-826 Workflow for Retinal Signaling Studies
2026-08-16
Build more informative retinal neuron-survival assays by pairing BAY-826 pharmacology with Müller cell co-culture, hypoxia, and orthogonal pathway readouts. This guide separates the reported biochemical potency of the compound from cellular-response variables, helping researchers improve dose selection, controls, and troubleshooting.
-
miR-1268a, CD36, and Angiotensin II Heart Failure
2026-08-15
A 2024 study identifies miR-1268a as a regulator of CD36-dependent fatty acid uptake, ATP production, and oxidative stress in Angiotensin II-treated AC16 cardiomyocytes. Its main contribution is a mechanistic link between microRNA dysregulation and metabolic impairment in an in vitro heart failure model, while its findings still require validation in primary cells and animal systems.